INDRANIB · INDRAYANI BIOTECH LTD. · Financials
Market Cap
408.92M INR
Shares
45.54M
Volume · Nov 13
71.26K
Avg daily vol (3M)
58.85K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
1.38B
+5.8%
FY2026
Net Income
3.78M
+106.2%
FY2026
Operating Cash Flow
319.48M
+573.9%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 |
|---|---|---|---|
| INR | 1.46B | 1.38B | 1.3B |
| INR | 45.39M | 43.01M | 33.68M |
| INR | 88.05M | 96.01M | 117.62M |
| INR | 6.8M | 3M | -57.44M |
| INR | -18.64M | -16.6M | 3.64M |
| INR | 7.87M | 3.78M | -61.08M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 0 in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.